The Solutions Proposed by Da Volterra
“We can no longer afford to be indifferent to the spread of drug resistant diseases. We must shows collective leadership if we are to meet this challenge. For the sake of all people who deserve life-saving care when their health is imperiled, now and in the future, drug resistance must be addressed urgently and aggressively as a global health priority.”
Center for Global Development, The Race Against Bacterial Resistance Report, 2011.
A Critical Situation Welcoming Novel Solutions
The global community can no longer take antibiotics for granted, nor ignore the emergence of resistance. The rise in bacterial resistance may pave the way for major epidemics. People in developed countries now find it hard to imagine that a simple scratch once carried the risk of infection and death. Yet despite the introduction of antibiotic resistance containment and stewardship programs, the risk is real that untreatable multi-drug resistant infections become more and more common. Situations of therapeutic impasse may recur increasingly frequently in the forthcoming years.
Preserving the lifespan of the presently available antibiotics is an urgent need for the commonweal and future generations. Consequently, interventions to avoid the initial development and/or dissemination of antibiotic resistance must be considered key public health policies. Antibiotics have been regarded for far too long as inexhaustible gifts, stripped of their value through misuse and overdose.
A Dramatic Need. A Great Potential.
Because all infectious diseases cannot be eradicated, Da Volterra’s ambition is to prevent the amplification and dissemination of antibiotic resistance at the root - to keep infectious diseases in check with the available arsenal. Da Volterra’s innovative approach focuses on minimizing the risk of amplification and dissemination of resistance to antibiotics, specifically in the colon which is recognized as a reservoir of resistance.
Da Volterra’s pioneering strategies are completing current strategies to combat resistance such as public health policies (antibiotic stewardship programs, hygiene measures), early rapid diagnostics, development of new drugs and antimicrobial vaccines. Da Volterra aims at enhancing the therapeutic and hence economic value of antibiotics.
One World, One Health
For Da Volterra, the challenge of reducing the antibiotic footprint in the environment is also closely interconnected with the antimicrobial resistance issue. The company's commitment meets a vision in which Patient, People, Ethics and Planet make one, with one health that needs to be preserved for today and future generations.
